Atypical femoral fractures bilaterally in a patient receiving denosumab

Acta Orthop. 2014 Feb;85(1):3-5. doi: 10.3109/17453674.2013.854668. Epub 2013 Oct 31.

Authors

Efstathios Drampalos¹, George Skarpas, Nikos Barbounakis, Ioannis Michos

Affiliation

¹ Department of Orthopedics , Broomfield Hospital, Essex , UK ;

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Alendronate / adverse effects
Alendronate / therapeutic use
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Bone Density Conservation Agents / administration & dosage
Bone Density Conservation Agents / adverse effects*
Bone Density Conservation Agents / therapeutic use
Denosumab
Drug Administration Schedule
Female
Femoral Fractures / chemically induced*
Femoral Fractures / diagnostic imaging
Fractures, Stress / chemically induced*
Fractures, Stress / diagnostic imaging
Humans
Osteoporosis, Postmenopausal / drug therapy
Osteoporotic Fractures / prevention & control
Radiography

Substances

Antibodies, Monoclonal, Humanized
Bone Density Conservation Agents
Denosumab
Alendronate